| The results suggest that as a tumor suppressor miRNA, miR-183 plays an important role in the aggressiveness of osteosarcoma. | osteosarcoma, |
| Demonstrate that miR-183 acts as a tumor suppressor in gastric cancer, partially at least via regulation of Ezrin. | gastric, |
| MicroRNA-183 functions as the tumor suppressor via inhibiting cellular invasion and metastasis by targeting MMP-9 in cervical cancer | cervical, |
| MicroRNA-183 Acts as a Tumor Suppressor in Human Non-Small Cell Lung Cancer by Down-Regulating MTA1 | lung, |
| Potential Role of microRNA-183 as a Tumor Suppressor in Hepatocellular Carcinoma | liver, |
| miR-183-5p functions as a tumor suppressor in lung cancer through PIK3CA inhibition | lung, |
| Therefore, our study demonstrates that miR-183 is a tumor suppressor microRNA that plays a major role in OS. | None |
| microRNA-183 is an oncogene targeting Dkk-3 and SMAD4 in prostate cancer. | prostate, |
| microRNA-183 plays as oncogenes by increasing cell proliferation, migration and invasion via targeting protein phosphatase 2A in renal cancer cells. | kidney, |
| The miR-183/-96/-182 cluster is up-regulated in most breast cancer. It functions as an oncogene in breast cancer as it increases cell proliferation and migration. | breast, |
| Data suggest that miR-183 might play an oncogenic role in esophageal squamous cell carcinoma by regulating PDCD4 expression. | esophageal, |
| miR-183 may act as a potential tumor oncogene in lung adenocarcinomas. | lung, |
| The miR-183 maybe function as an oncogene by regulating gastric cancer cell proliferation, apoptosis and metastasis and the oncogenic effect of miR-183 may relate the direct targeting PDCD4. | gastric, |
| TFAP2C might increase oncogenic miR-183 expression and consequently downregulate tumor-suppressive AKAP12 and decrease tumor-suppressive miR-33a expression and subsequently induce CDK6 in NSCLC cells | lung, |
| we conclude that miR1835p acts as an oncogene in lung adenocarcinoma and participates in the pathogenesis of lung adenocarcinoma via the interaction networks of its target genes | lung, |
| After controlling for gender, age, tumor size and tumor stage in the multivariate analysis, renal cell carcinoma (RCC)patients with high expression of miR-183-5p have worse prognosis after surgery and shorter overall survival. The results support the oncogene role of miR-183-5p in RCC. | kidney, |
| Data show that miR-183 has a potential oncogenic role through the regulation of 2 tumor suppressor genes, EGR1 and PTEN, and the deregulation of this fundamental miRNA regulatory network may be central to many tumor types. | None |
| MicroRNA miR-183 functions as an oncogene by targeting the transcription factor EGR1 and promoting tumor cell migration. | None |
| miR-183 may function as an oncogene and may enhance cell proliferation by targeting PDCD6, implying a potential therapeutic target for this malignancy. | None |